Two Sigma Advisers’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $615K | Buy |
144,400
+6,400
| +5% | +$27.3K | ﹤0.01% | 1655 |
|
|
2025
Q1 | $519K | Buy |
138,000
+49,000
| +55% | +$184K | ﹤0.01% | 1763 |
|
|
2024
Q4 | $519K | Sell |
89,000
-12,200
| -12% | -$71.1K | ﹤0.01% | 1762 |
|
|
2024
Q3 | $1.21M | Sell |
101,200
-28,300
| -22% | -$338K | ﹤0.01% | 1321 |
|
|
2024
Q2 | $1.4M | Sell |
129,500
-19,000
| -13% | -$206K | ﹤0.01% | 1386 |
|
|
2024
Q1 | $1.68M | Sell |
148,500
-32,300
| -18% | -$366K | ﹤0.01% | 1312 |
|
|
2023
Q4 | $2.54M | Sell |
180,800
-59,000
| -25% | -$828K | 0.01% | 1154 |
|
|
2023
Q3 | $2.96M | Sell |
239,800
-1,100
| -0.5% | -$13.6K | 0.01% | 992 |
|
|
2023
Q2 | $2.18M | Buy |
240,900
+35,000
| +17% | +$316K | 0.01% | 1153 |
|
|
2023
Q1 | $714K | Sell |
205,900
-20,500
| -9% | -$71.1K | ﹤0.01% | 1794 |
|
|
2022
Q4 | $555K | Sell |
226,400
-158,100
| -41% | -$387K | ﹤0.01% | 1841 |
|
|
2022
Q3 | $1.06M | Sell |
384,500
-129,300
| -25% | -$357K | ﹤0.01% | 1493 |
|
|
2022
Q2 | $2.09M | Sell |
513,800
-101,600
| -17% | -$413K | 0.01% | 1190 |
|
|
2022
Q1 | $2.62M | Buy |
615,400
+47,400
| +8% | +$202K | 0.01% | 1098 |
|
|
2021
Q4 | $5.32M | Buy |
568,000
+558,700
| +6,008% | +$5.23M | 0.01% | 737 |
|
|
2021
Q3 | $256K | Buy |
+9,300
| New | +$256K | ﹤0.01% | 2176 |
|